Skip to main content
. 2022 Nov 29;15:2573–2581. doi: 10.2147/CCID.S383289

Table 3.

Relationship Between Disease Severity and Efficacy Evaluation in Each Treatment Times Group

Treatment Week Mild Improvement Moderate Improvement Marked Improvement P value (Wilcoxon Test)
≥12 week number Severe 0 2 (15.4) 0 0.272
Moderate 6 (46.2) 4 (30.8) 1 (7.7)
12 > week number ≥8 Severe 3 (9.7) 1 (3.2) 6 (19.4) 0.111
Moderate 9 (29.0) 8 (25.8) 4 (12.9)
8 > week number ≥4 Severe 0 0 1 (3.6) 0.088
Moderate 12 (42.9) 13(46.4) 2 (7.1)
4> week number ≥1 Severe 1 (9.1) 0 0 0.306
Moderate 4 (36.4) 4 (36.4) 2 (18.2)